260
Participants
Start Date
September 23, 2022
Primary Completion Date
February 6, 2026
Study Completion Date
February 6, 2026
Bemarituzumab
Intravenous (IV) infusion.
Semmelweis Egyetem, Budapest
Orszagos Onkologiai Intezet, Budapest
Universite Catholique de Louvain Cliniques Universitaires Saint Luc, Brussels
Hopitaux Universitaires de Geneve, Geneva
Centro Oncologico Korben, Buenos Aires
Military Medical Academy Multiprofile Hospital for Active Treatment - Sofia, Sofia
Hospital Italiano de La Plata, La Plata
Prince of Wales Hospital, Randwick
Rigshospitalet, København Ø
Liverpool Hospital, Liverpool
Wollongong Hospital, Wollongong
Universitair Ziekenhuis Antwerpen, Edegem
Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven
Cabrini Hospital, Malvern
Multiprofile Hospital for Active Treatment Central Onco Hospital OOD, Plovdiv
Complex Oncology Center Plovdiv EOOD, Plovdiv
Toowoomba Hospital, Toowoomba
Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz Nyiregyhazi Josa Andras Tagkorhaz, Nyíregyháza
Sociedad de Beneficencia Hospital Italiano, Córdoba
Jasz-Nagykun-Szolnok Varmegyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok
Landeskrankenhaus Salzburg, Salzburg
Grand Hopital de Charleroi - Site des Viviers, Charleroi
St John of God Murdoch Hospital, Murdoch
Kantonsspital Graubuenden, Chur
Medizinische Universitaet Graz, Graz
Fundacion Medica de Rio Negro y Neuquen, Cipolletti
Universitair Ziekenhuis Gent, Ghent
Istituto di Candiolo Fondazione del Piemonte per l Oncologia IRCCS, Candiolo to
Sotiria General Hospital, Athens
Alexandra Hospital, Athens
Institut Paoli Calmettes, Marseille
Metropolitan General, Athens
Hospital Clinico Universitario de Santiago, Santiago de Compostela
Investigacion Onco Farmacéutica S de RL de CV, La Paz
Centre Hospitalier Regional Universitaire de Besancon - Hopital Jean Minjoz, Besançon
Centro de Infusion e Investigacion Oncologia de Saltillo, Saltillo
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Clinico Universitario Virgen de la Victoria, Málaga
Azienda Unita Locale Socio Sanitaria 3 Presidio Ospedaliero di Mirano, Mirano
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse
Tampere University Hospital, Tampere
Institut regional du Cancer Montpellier, Montpellier
United States Oncology Regulatory Affairs Corporate Office, Nashville
Community Health Network MD Anderson Cancer Center - North, Indianapolis
Henry Ford Hospital, Detroit
Institut de Cancerologie de l Ouest Rene Gauducheau, Angers
Azienda Ospedaliero Universitaria Pisana, Pisa
European Interbalkan Medical Center, Thessaloniki
Centre Oscar Lambret, Lille
Christus Muguerza Clinica Vidriera, Monterrey
Hopital Lyon sud, Pierre-Bénite
Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia, Foggia
University Hospital of Heraklion, Heraklion - Crete
US Oncology Research Investigational Products Center, Irving
Texas Oncology - Dallas Fort Worth, Dallas
Texas Oncology Northeast Texas, Tyler
University of Texas MD Anderson Cancer Center, Houston
Rocky Mountain Cancer Centers, Aurora
Ospedale del Mare, Napoli
City of Hope National Medical Center, Duarte
University of California Irvine, Orange
Gustave Roussy, Villejuif
Centrul de Oncologie Sf Nectarie SRL, Craiova
SC Oncomed SRL, Timișoara
Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca, Cluj-Napoca
Institutul Regional de Oncologie Iasi, Iași
Rambam Medical Center, Haifa
Rabin Medical Center, Petah Tikva
Sheba Medical Center, Ramat Gan
Tel-Aviv Sourasky Medical Center, Tel Aviv
Hadassah Ein-Kerem Medical Center, Jerusalem
Instituto Alexander Fleming, Capital Federal
Hospital Aleman, Ciudad Autonoma de Buenos Aires
Fundacion Cenit Para La Investigacion, Ciudad Autonoma de Buenos Aires
Hospital das Clinicas da Ufmg, Belo Horizonte
Centro de Oncologia Mackenzie, Curitiba
Associacao Hospitalar Moinhos de Vento, Porto Alegre
Instituto do Cancer Arnaldo Vieira de Carvalho, São Paulo
Beneficencia Portuguesa de Sao Paulo - Bp, São Paulo
Oncologia Rede D Or, São Paulo
Oncoclinicas Rio de Janeiro S A, Rio de Janeiro
Cross Cancer Institute, Edmonton
The Ottawa Hospital Cancer Centre, Ottawa
Princess Margaret Cancer Centre, Toronto
Masarykuv onkologicky ustav, Brno
Fakultni nemocnice Hradec Kralove, Hradec Králové
Fakultni nemocnice Olomouc, Olomouc
Fakultni nemocnice Kralovske Vinohrady, Prague
Docrates Syopasairaala, Helsinki
Azienda Ospedaliera Policlinico Umberto I, Roma
Aichi Cancer Center, Nagoya
National Cancer Center Hospital East, Kashiwa-shi
Kindai University Hospital, Osakasayama-shi
National Cancer Center Hospital, Chuo-ku
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku
Health Pharma Professional Research SA de CV, Mexico City
Investigacion Biomedica para el Desarrollo de Farmacos, Mexico City
Universitair Medisch Centrum Groningen, Groningen
Radboud Universitair Medisch Centrum, Nijmegen
Pratia Mcm Krakow, Krakow
Instytut Centrum Zdrowia Matki Polki, Lodz
Ars Medical Spzoo, Piła
Mazowiecki Szpital Wojewodzki im Sw Jana Pawla II w Siedlcach spzoo, Siedlce
Centrum Medyczne Pratia Poznan, Skorzewo
Unidade Local de Saude de Lisboa Ocidental, EPE - Hospital Sao Francisco Xavier, Lisbon
Hospital da Luz, SA, Lisbon
Unidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria, Lisbon
Seoul National University Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Samsung Medical Center, Seoul
Asan Medical Center, Seoul
Hospital Quironsalud Barcelona, Barcelona
Hospital Universitari Vall d Hebron, Barcelona
Christie Hospital, Manchester
Weston Park Hospital, Sheffield
Lead Sponsor
Amgen
INDUSTRY